Treatment of autoimmune MRL/lpr mice with anti-B220 monoclonal antibody reduces the level of anti-DNA antibodies and lymphadenopathies.

por Asensi, V, Kimeno, K, Kawamura, I, Sakumoto, M, Nomoto, K
Publicado em 1989

In vivo treatment with anti B-220 monoclonal antibody affects T and B cell differentiation.

por Asensi, V, Himeno, K, Kawamura, I, Sakumoto, M, Nomoto, K
Publicado em 1990

Factors predictive of relapse in adult bacterial osteomyelitis of long bones.

por Garcia del Pozo, E., Collazos, J., Carton, J. A., Camporro, D., Asensi, V.
Publicado no BMC Infect Dis (2018)

Unusual complications in the Churg-Strauss syndrome

por Alvarez, C, Asensi, V, Rodriguez-Guardad..., A, Casado, L, Ablanedo, P, Alvarez-Navascues, C
Publicado em 2002

The effect of gender and genetic polymorphisms on matrix metalloprotease (MMP) and tissue inhibitor (TIMP) plasma levels in different infectious and non-infectious conditions

por Collazos, J, Asensi, V, Martin, G, Montes, A H, Suárez-Zarracina, T, Valle-Garay, E
Publicado no Clin Exp Immunol (2015)

Hydroxy-chloroquine to treat COVID-19 – infected patients: Some lessons from medical anthropology and history of medicine

por Charlier, P., Donell, S., Lippi, D., Nerlich, A., Asensi, V., Perciaccante, A., Appenzeller, O., Bianucci, R.
Publicado no Ethics Med Public Health (2020)

The IL-1β (+3953 T/C) gene polymorphism associates to symptomatic lumbar disc herniation

por Paz Aparicio, J., Fernández Bances, I., López-Anglada Fernández, E., Montes, A. H., Paz Aparicio, A., Pena Vázquez, J., Ramos García, S., Antón García, S., López Fernández, P., Valle-Garay, E., Asensi, V.
Publicado em 2011

Factors associated with sepsis development in 606 Spanish adult patients with cellulitis

por Collazos, J., de la Fuente, B., de la Fuente, J., García, A., Gómez, H., Menéndez, C., Enríquez, H., Sánchez, P., Alonso, M., López-Cruz, I., Martín-Regidor, M., Martínez-Alonso, A., Guerra, J., Artero, A., Blanes, M., Asensi, V.
Publicado no BMC Infect Dis (2020)

Sustained virological response in HIV/HCV co-infected patients without rapid virological response (RVR) on peginterferon-ribavirin therapy

por Labarga, P, Vispo, ME, Guardiola, JM, Miralles, C, Martín-Carbonero, L, Portu, J, Barreiro, P, Miralles, P, Morello, J, Tellez, MJ, Bancalero, P, Asensi, V, Rallón, NI, Santos, I, Morano, L, Aguirrebengoa, K, Rios, MJ, Rubio, R, Neukam, K, González-Lahoz, J, Soriano, V
Publicado em 2010